Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No Evidence for Clade I Monkeypox Virus Circulation, Belgium.
Liesenborghs L, Coppens J, Van Dijck C, Brosius I, De Baetselier I, Vercauteren K, Van Esbroeck M. Liesenborghs L, et al. Among authors: brosius i. Emerg Infect Dis. 2024 Feb;30(2):402. doi: 10.3201/eid3002.231746. Epub 2024 Jan 8. Emerg Infect Dis. 2024. PMID: 38190761 Free PMC article. No abstract available.
Antimalarial artesunate-mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial.
Bottieau E, Mbow M, Brosius I, Roucher C, Gueye CT, Mbodj OT, Faye BT, De Hondt A, Smekens B, Arango D, Burm C, Tsoumanis A, Paredis L, Van Herrewege Y, Potters I, Richter J, Rosanas-Urgell A, Cissé B, Mboup S, Polman K. Bottieau E, et al. Among authors: brosius i. Nat Med. 2024 Jan;30(1):130-137. doi: 10.1038/s41591-023-02719-4. Epub 2024 Jan 4. Nat Med. 2024. PMID: 38177851 Free PMC article. Clinical Trial.
Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T Cells.
Vujkovic A, Ha M, de Block T, van Petersen L, Brosius I, Theunissen C, van Ierssel SH, Bartholomeus E, Adriaensen W, Vanham G, Elias G, Van Damme P, Van Tendeloo V, Beutels P, van Frankenhuijsen M, Vlieghe E, Ogunjimi B, Laukens K, Meysman P, Vercauteren K. Vujkovic A, et al. Among authors: brosius i. J Infect Dis. 2024 Feb 14;229(2):507-516. doi: 10.1093/infdis/jiad430. J Infect Dis. 2024. PMID: 37787611 Free PMC article.
Beware of drug resistance: Let's not lose tecovirimat against mpox.
Van Dijck C, Crozier I, Vercauteren K, Brosius I, Mbala-Kingebeni P, Dodd L, Bottieau E, Tshiani Mbaya O, Nussenblatt V, Neyts J, Liesenborghs L. Van Dijck C, et al. Among authors: brosius i. Clin Microbiol Infect. 2024 Mar;30(3):276-278. doi: 10.1016/j.cmi.2023.09.014. Epub 2023 Sep 22. Clin Microbiol Infect. 2024. PMID: 37741622 No abstract available.
Tecovirimat Resistance in an Immunocompromised Patient With Mpox and Prolonged Viral Shedding.
Mertes H, Rezende AM, Brosius I, Naesens R, Michiels J, deBlock T, Coppens J, Van Dijck C, Bomans P, Bottieau E, Van Esbroeck M, Ariën KK, Liesenborghs L, Vercauteren K. Mertes H, et al. Among authors: brosius i. Ann Intern Med. 2023 Aug;176(8):1141-1143. doi: 10.7326/L23-0131. Epub 2023 Jul 25. Ann Intern Med. 2023. PMID: 37487213 Free article. No abstract available.
Leveraging T-cell receptor - epitope recognition models to disentangle unique and cross-reactive T-cell response to SARS-CoV-2 during COVID-19 progression/resolution.
Postovskaya A, Vujkovic A, de Block T, van Petersen L, van Frankenhuijsen M, Brosius I, Bottieau E, Van Dijck C, Theunissen C, van Ierssel SH, Vlieghe E, Bartholomeus E, Mullan K, Adriaensen W, Vanham G, Ogunjimi B, Laukens K, Vercauteren K, Meysman P. Postovskaya A, et al. Among authors: brosius i. Front Immunol. 2023 May 31;14:1130876. doi: 10.3389/fimmu.2023.1130876. eCollection 2023. Front Immunol. 2023. PMID: 37325653 Free PMC article.
Presymptomatic viral shedding in high-risk mpox contacts: A prospective cohort study.
Brosius I, Van Dijck C, Coppens J, Vandenhove L, Bangwen E, Vanroye F, Verschueren J; ITM MPOX Study Group; Zange S, Bugert J, Michiels J, Bottieau E, Soentjens P, van Griensven J, Kenyon C, Ariën KK, Van Esbroeck M, Vercauteren K, Liesenborghs L. Brosius I, et al. J Med Virol. 2023 May;95(5):e28769. doi: 10.1002/jmv.28769. J Med Virol. 2023. PMID: 37212312
Characteristics of confirmed mpox cases among clinical suspects: A prospective single-centre study in Belgium during the 2022 outbreak.
Hens M, Brosius I, Berens-Riha N, Coppens J, Van Gestel L, Rutgers J, Kenyon C, Soentjens P, van Henten S, Bracke S, Vanbaelen T, Vandenhoven L, Bottieau E, Vercauteren K, Van Esbroeck M, Liesenborghs L, Van Dijck C; ITM mpox study groupc; ITM mpox study group. Hens M, et al. Among authors: brosius i. New Microbes New Infect. 2023 Feb 9;52:101093. doi: 10.1016/j.nmni.2023.101093. eCollection 2023 Mar. New Microbes New Infect. 2023. PMID: 36874154 Free PMC article.
Persistent morbidity in Clade IIb mpox patients: interim results of a long-term follow-up study, Belgium, June to November 2022.
Berens-Riha N, Bracke S, Rutgers J, Burm C, Van Gestel L, Hens M, Kenyon C, Bottieau E, Soentjens P, Brosius I, Van Esbroeck M, Vercauteren K, van Griensven J, van Dijck C, Liesenborghs L; ITM monkeypox study group; Members of the ITM Monkeypox Study Group. Berens-Riha N, et al. Among authors: brosius i. Euro Surveill. 2023 Feb;28(7):2300072. doi: 10.2807/1560-7917.ES.2023.28.7.2300072. Euro Surveill. 2023. PMID: 36795501 Free PMC article.
Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022.
Berens-Riha N, De Block T, Rutgers J, Michiels J, Van Gestel L, Hens M; ITM monkeypox study group; Kenyon C, Bottieau E, Soentjens P, van Griensven J, Brosius I, Ariën KK, Van Esbroeck M, Rezende AM, Vercauteren K, Liesenborghs L; ITM Monkeypox Study Group. Berens-Riha N, et al. Among authors: brosius i. Euro Surveill. 2022 Dec;27(48):2200894. doi: 10.2807/1560-7917.ES.2022.27.48.2200894. Euro Surveill. 2022. PMID: 36695462 Free PMC article.
23 results